Health effects classification and its role in the derivation of minimal risk levels: Immunological effects

被引:20
作者
Abadin, H. G. [1 ]
Chou, C. -H. S. J.
Llados, F. T.
机构
[1] Agcy Tox Subst & Dis Registry, Div Toxicol & Environm Med, Atlanta, GA USA
[2] Syracuse Res Corp, Syracuse, NY USA
关键词
minimal risk level; immunological; risk assessment; screening levels; immune system; health effect classification; THYMUS-DEPENDENT IMMUNITY; MACACA-MULATTA MONKEY; UNCERTAINTY FACTORS; PCB AROCLOR-1254; HOST-RESISTANCE; SAFETY FACTORS; LYMPHOCYTE-B; MICE; IMMUNOTOXICITY; EXPOSURE;
D O I
10.1016/j.yrtph.2006.11.001
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
The Agency for Toxic Substances and Disease Registry (ATSDR) derives health-based guidance values known as minimal risk levels (MRLs). By definition, an MRL is a substance-specific estimate of the daily human exposure to a substance that is likely to be without an appreciable risk of adverse, noncancer effects over a specified duration of exposure. MRLs are preferentially derived from human studies, if available, or from the most sensitive animal species and the endpoint that is most relevant for humans. To date, the agency has derived 346 MRLs. Fifteen MRLs were derived for 11 different chemicals where the database has identified the immune system as the most sensitive target of toxicity. The chemicals include benzene, chlorfenvinphos, endosulfan, heptachlor, gamma-hexachlorocyclohexane, dibutyl tin, tributyl tin, PCBs, 2,3,4,7,8-pentachlorodibenzofuran, 2,3,7,8-tetrachlorodibenzo-p-dioxin, and 2,4-dichlorophenol. The agency's rationale for classification of immunological endpoints is discussed and a brief description given of the critical studies selected for MRL development using immune system endpoints. Published by Elsevier Inc.
引用
收藏
页码:249 / 256
页数:8
相关论文
共 40 条
[1]  
[Anonymous], 1994, EPA600890066F
[2]  
*ATSDR, 1994, IMM FUNCT TEST BATT
[3]  
*ATSDR, 2005, ATSDR TOXPROFILES 20
[4]   EFFECT OF SUBCHRONIC ENDOSULFAN EXPOSURE ON HUMORAL AND CELL-MEDIATED IMMUNE-RESPONSES IN ALBINO-RATS [J].
BANERJEE, BD ;
HUSSAIN, QZ .
ARCHIVES OF TOXICOLOGY, 1986, 59 (04) :279-284
[5]   REFERENCE DOSE (RFD) - DESCRIPTION AND USE IN HEALTH RISK ASSESSMENTS [J].
BARNES, DG ;
DOURSON, M .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1988, 8 (04) :471-486
[6]   Epidemiology studies in immunotoxicity evaluations [J].
Biagini, RE .
TOXICOLOGY, 1998, 129 (01) :37-54
[7]   Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on influenza virus host resistance in mice [J].
Burleson, GR ;
Lebrec, H ;
Yang, YG ;
Ibanes, JD ;
Pennington, KN ;
Birnbaum, LS .
FUNDAMENTAL AND APPLIED TOXICOLOGY, 1996, 29 (01) :40-47
[8]  
Burns-Nass LE., 2001, CASARETT DOULLS TOXI, P419
[9]   DOES THE ANIMAL-TO-HUMAN UNCERTAINTY FACTOR INCORPORATE INTERSPECIES DIFFERENCES IN SURFACE-AREA [J].
CALABRESE, EJ ;
BECK, BD ;
CHAPPELL, WR .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1992, 15 (02) :172-179
[10]   LACK OF TOTAL INDEPENDENCE OF UNCERTAINTY FACTORS (UFS) - IMPLICATIONS FOR THE SIZE OF THE TOTAL UNCERTAINTY FACTOR [J].
CALABRESE, EJ ;
GILBERT, CE .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1993, 17 (01) :44-51